Prabhudas Lilladher's research report on Colgate Palmolive
CLGT’s 2Q results are in line with 3% volume growth, 18% EBIDTA growth and 22.3% PAT growth led by 500bps higher gross margins partly neutralized by 260bps higher ad-spends. Our estimates indicate that 2Q indexed volumes are up by just 6.5% over FY20-24 and current volume growth is driven by low base of 5 consecutive negative volume quarters before 1Q24. CLGT continues to focus on 1) driving toothpaste category penetration and usage 2) premiumisation through science-based innovations with Total and Colgate strong teeth and 3) build personal care portfolio in body/hand wash. While CLGT is launching premium products (Total Sensitive Toothpaste, CLGT water flosser, Visible white O2 TP & Whitening Pen and Colgate Periogard Toothpaste), their contribution will remain limited in medium term. While resilient urban demand, low base and benign inputs will enable strong growth in FY24, sustaining double digit PAT growth beyond FY24 looks challenging but for significant pick up in rural demand.
Outlook
We estimate 8.0% sales and 11% PAT CAGR over FY23-26. We value CLGT at 38x Sep’25 EPS and assign a target of Rs1948 (Rs1869 earlier). Re-rating potential seems capped post recent run up in stock price. Retain Hold.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!